Y-590 (A new pyridazinone derivative), a potent anti-thrombotic agent — II. Inhibition of platelet phosphodiesterase

This publication has 10 references indexed in Scilit:

• Y-590 (A new pyridazinone derivative), a potent anti-thrombotic agent — I. Effect on platelet function
  Thrombosis Research, 1983
• Comparison of sulfinpyrazone and BL-3459 with S - 20344, a potent new antithrombotic agent
  Thrombosis Research, 1981
• SELECTIVE INHIBITOR OF PLATELET CYCLIC ADENOSINE-MONOPHOSPHATE PHOSPHODIESTERASE, CILOSTAMIDE, INHIBITS PLATELET-AGGREGATION
  1979
• DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN
  The Lancet, 1978
• Clinical pharmacology of platelets
  Blood, 1977
• Modulation of human platelet adenylate cyclase by prostacyclin (PGX)
  Prostaglandins, 1977
• CLINICAL PHARMACOLOGY OF PLATELETS
  1977
• A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  Prostaglandins, 1976
• Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: Possible explanation of mechanism of inhibition of platelet function
  Life Sciences, 1975
• The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′:5′-cyclic monophosphate in platelets
  Biochemical Journal, 1971